Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes
ClinicalTrials.gov study NCT06476119. IPD Sharing: NO. Countries: 1. Publications: 0.
Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)
ClinicalTrials.gov study NCT07255612. IPD Sharing: NO. Countries: 1. Publications: 0.
HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06849492. IPD Sharing: NO. Countries: 1. Publications: 0.
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
ClinicalTrials.gov study NCT06238921. IPD Sharing: NO. Countries: 1. Publications: 0.
The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02539017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02672475. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05539365. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer
ClinicalTrials.gov study NCT05093387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients
ClinicalTrials.gov study NCT05632848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
ClinicalTrials.gov study NCT03907800. IPD Sharing: NO. Countries: 1. Publications: 0.
Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05746728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT05673200. IPD Sharing: YES. Countries: 1. Publications: 0.
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04427293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genome-wide effects of the maternal embryonic leucine zipper kinase (MELK) in triple-negative breast cancer cells indicate context-dependent effects and p53 as a key determinant
GEO Series GSE68693. Homo sapiens. 10 samples. Type: Expression profiling by array.
Regulation of ribosomal gene expression and senescence by a PML-mTOR-RONIN nuclear complex in triple-negative breast cancer
GEO Series GSE283109. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancer
GEO Series GSE267535. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
Triple-negative breast cancer cell lines treated with mebedazole (an FDA-approved anti-parasitic).
GEO Series GSE190845. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Molecular effects of glucose on MIR503HG-regulated genes in triple-negative breast cancer
GEO Series GSE297214. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing.
SIPA1 Functions as a Transcription Regulator to Sustain Progression of Triple-Negative Breast Cancer
GEO Series GSE221743. Homo sapiens. 10 samples. Type: Expression profiling by high throughput sequencing.
Dishevelled-1 regulates global transcriptomic changes in MDA-MB-231 triple negative breast cancer cells (RNA-Seq).
GEO Series GSE249322. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.